Page values for "WSI24-289-Case-4"

From MGH Learn Pathology

"_pageData" values

_creationDateApril 17, 2025
_modificationDateApril 17, 2025
_creatorSi787
_fullText{{ServiceRequestCase |identifier=WSI24-289-Case-4 |intent=order |code=cme |category=409073007 |subject=MGH |requester=Jg67 |performer=Jg67 |orderDetail=case |locationCode=learn |access=public |status=active |origin=CPOE |priority=Routine |basedOn=WSI24-289 |requisition=Lower GI slide session- GI Pat ...
_numRevisions1
_isRedirectNo

"_fileData" values

"ServiceRequest" values

identifierWSI24-289-Case-4
basedOnWSI24-289
requisitionLower GI slide session- GI Pathology CME
intentorder
category409073007
priorityRoutine
codecme
orderDetailcase
subjectMGH
occurrenceDateTimeMay 12, 2025 4:00:00 PM
authoredOnApril 17, 2025 3:22:16 PM
requesterJg67
performerJg67
locationCodelearn
reasonCode75 y.o. male with metastatic non-small cell lung cancer on pembrolizumab. Diarrhea. ​ Colon: erythema friability​. EGD: gastric erythema otherwise normal
supportingInfoImmune checkpoint inhibitor therapy effect (pembrolizumab) in stomach and colon
sequence4
accesspublic

"status" values

statusactive
identifierWSI24-289-Case-4
requesterJg67
authoredOnApril 17, 2025 3:22:16 PM

"Media" values

identifierd0744f6c-714d-48b2-82e6-2fd80e6d935e
basedOnWSI24-289-Case-4
partOfWSI24-289
statuscompleted
typenull
modalitymrxs
viewshow
createdDateTimeApril 17, 2025 3:22:16 PM
operatorJg67
reasonCodeH&E
bodySitenull
frames1
contentd0744f6c-714d-48b2-82e6-2fd80e6d935e.mrxs
notenull
subjectnull
identifierd37ab621-bb88-473b-b8a5-50167a9e35fe
basedOnWSI24-289-Case-4
partOfWSI24-289
statuscompleted
typenull
modalitymrxs
viewshow
createdDateTimeApril 17, 2025 3:22:16 PM
operatorJg67
reasonCodeH&E
bodySitenull
frames2
contentd37ab621-bb88-473b-b8a5-50167a9e35fe.mrxs
notenull
subjectnull